PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines-Reference-Cited by-同舟云学术

PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines

Published:2017-02-20 Issue:14 Volume:8 Page:23213-23227
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ultimo Simona¹,Simioni Carolina¹,Martelli Alberto M.²,Zauli Giorgio¹,Evangelisti Camilla³,Celeghini Claudio⁴,McCubrey James A.⁵,Marisi Giorgia⁶,Ulivi Paola⁶,Capitani Silvano¹⁷,Neri Luca M.¹

Affiliation:

1. Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy

2. Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy

3. Institute of Molecular Genetics, Rizzoli Orthopedic Institute, National Research Council, Bologna, Italy

4. Department of Life Sciences, University of Trieste, Trieste, Italy

5. Department of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, NC, USA

6. Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e Cura dei Tumori (IRST) IRCCS, Meldola, Italy

7. LTTA Center, University of Ferrara, Ferrara, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of Autophagy and Apoptosis in Leukemia;Reference Module in Biomedical Sciences;2024

2. PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities;Cancers;2023-11-05

3. Targeting Class I-II-III PI3Ks in Cancer Therapy: Recent Advances in Tumor Biology and Preclinical Research;Cancers;2023-01-27

4. Synergistic effects of PI3K inhibition and pioglitazone against acute promyelocytic leukemia cells;Molecular Genetics & Genomic Medicine;2022-11-18

5. Enhancing autophagy in Alzheimer's disease through drug repositioning;Pharmacology & Therapeutics;2022-09